AVEO Oncology, an LG Chem company, Presents Two Posters for Tivozanib at the 2025 ASCO GU Meeting
Hand-out
Press Releases
AVEO, an LG Chem company  
February 18, 2025

AVEO Oncology, an LG Chem company, Presents Two Posters for Tivozanib at the 2025 ASCO GU Meeting

– Cumulative data of three Phase 3 studies demonstrate greater exposure of tivozanib is associated with increased clinical benefit –

logo salamanca press

Salamanca Press

Local & Social